Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes

Drug Metabolism and Disposition

Volumn 40, Issue 9, 2012, Pages 1797-1802

  Stephens, Eva S ^a   Walsh, Agnes A ^a   Scott, Emily E ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIMETHYLAMINOBENZALDEHYDE; 4 NITROPHENOL; COUMARIN; CYTOCHROME P450 2A; CYTOCHROME P450 2A13; CYTOCHROME P450 2A6; CYTOCHROME P450 INHIBITOR; ENZYME INHIBITOR; MENTHOFURAN; METHOXSALEN; NICOTINE; NICOTYRINE; PHENACETIN; PHENETHYL ISOTHIOCYANATE; PILOCARPINE; RECOMBINANT ENZYME; TRANYLCYPROMINE; TRYPTAMINE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; BINDING AFFINITY; CATALYSIS; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG SELECTIVITY; ENZYME INHIBITION; EVALUATION; NONHUMAN; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; BINDING, COMPETITIVE; CATALYSIS; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; HYDROXYLATION; LIGANDS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; MONOTERPENES; NITROPHENOLS; PROTEIN BINDING; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TRANYLCYPROMINE;

EID: 84864545260     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.045161     Document Type: Article

References (29)

1. Bao Z, He XY, Ding X, Prabhu S, and Hong JY (2005) Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab Dispos 33:258-261. (Pubitemid 40216593)
2. Denton TT, Zhang X, and Cashman JR (2004) Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochem Pharmacol 67:751-756. (Pubitemid 38125259)
3. DeVore NM, Smith BD, Urban MJ, and Scott EE (2008) Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes. Drug Metab Dispos 36:2582-2590.
4. DeVore NM, Smith BD, Wang JL, Lushington GH, and Scott EE (2009) Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes. Drug Metab Dispos 37:1319-1327.
5. DeVore NM, Meneely KM, Bart AG, Stephens ES, Battaile KP, and Scott EE (2012) Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine. FEBS J 279:1621-1631.
6. Diaz GJ and Squires EJ (2000) Metabolism of 3-methylindole by porcine liver microsomes: responsible cytochrome P450 enzymes. Toxicol Sci 55:284-292. (Pubitemid 30353235)
7. Fukami T, Katoh M, Yamazaki H, Yokoi T, and Nakajima M (2008) Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and toluene. Chem Res Toxicol 21:720-725. (Pubitemid 351498048)
8. Fukami T, Nakajima M, Sakai H, Katoh M, and Yokoi T (2007) CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. Drug Metab Dispos 35:335-339. (Pubitemid 46333918)
9. Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559-603.
10. Holmans PL, Shet MS, Martin-Wixtrom CA, Fisher CW, and Estabrook RW (1994) The high-level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome b5 and studies on their mechanism of function. Arch Biochem Biophys 312:554-565.
11. Khojasteh SC, Prabhu S, Kenny JR, Halladay JS, and Lu AY (2011) Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 36:1-16.
12. Khojasteh-Bakht SC, Koenigs LL, Peter RM, Trager WF, and Nelson SD (1998) (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6. Drug Metab Dispos 26:701-704. (Pubitemid 28345854)
13. Koenigs LL, Peter RM, Thompson SJ, Rettie AE, and Trager WF (1997) Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab Dispos 25:1407-1415. (Pubitemid 28010927)
14. Mast N, Charvet C, Pikuleva IA, and Stout CD (2010) Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J Biol Chem 285:31783-31795.
15. Miyazawa M and Haigou R (2011) Determination of cytochrome P450 enzymes involved in the metabolism of (-)-terpinen-4-ol by human liver microsomes. Xenobiotica 41:1056-1062.
16. Nakajima M, Yoshida R, Shimada N, Yamazaki H, and Yokoi T (2001) Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab Dispos 29:1110-1113. (Pubitemid 32660529)
17. Pavek P and Dvorak Z (2008) Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129-143. (Pubitemid 351461002)
18. Rahnasto M, Wittekindt C, Juvonen RO, Turpeinen M, Petsalo A, Pelkonen O, Poso A, Stahl G, Höltje HD, and Raunio H (2008) Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme-an in silico approach. Pharmacogenomics J 8:328-338.
19. Schenkman JB and Jansson I (2006) Spectral analyses of cytochromes P450. Methods Mol Biol 320:11-18.
20. Shen AL, Porter TD, Wilson TE, and Kasper CB (1989) Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J Biol Chem 264:7584-7589. (Pubitemid 19119176)
21. Smith BD, Sanders JL, Porubsky PR, Lushington GH, Stout CD, and Scott EE (2007) Structure of the human lung cytochrome P450 2A13. J Biol Chem 282:17306-17313. (Pubitemid 47093207)
22. Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, and Ding X (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074-5079.
23. Taavitsainen P, Juvonen R, and Pelkonen O (2001) In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab Dispos 29:217-222. (Pubitemid 32179519)
24. von Weymarn LB, Chun JA, and Hollenberg PF (2006) Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. Carcinogenesis 27:782-790.
25. von Weymarn LB, Zhang QY, Ding X, and Hollenberg PF (2005) Effects of 8-methoxypsoralen on cytochrome P450 2A13. Carcinogenesis 26:621-629. (Pubitemid 41214152)
26. Yano JK, Denton TT, Cerny MA, Zhang X, Johnson EF, and Cashman JR (2006) Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem 49:6987-7001. (Pubitemid 44885987)
27. Yano JK, Hsu MH, Griffin KJ, Stout CD, and Johnson EF (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol 12:822-823. (Pubitemid 43086258)
28. Zhang JY, Wang Y, and Prakash C (2006) Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab 7:939-948. (Pubitemid 44873716)
29. Zhang W, Kilicarslan T, Tyndale RF, and Sellers EM (2001) Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos 29:897-902. (Pubitemid 32488648)